AAP
WST icon

Arax Advisory Partners’s West Pharmaceutical WST Stock Holding History

Arax Advisory Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Buy
3,908
+1,450
+59% +$443K 0.01% 1020
2026
Q1 		$616K Sell
2,458
-2,121
-46% -$528K 0.02% 570
2025
Q4 		$1.26M Sell
4,579
-18,063
-80% -$4.94M 0.04% 337
2025
Q3 		$5.94M Buy
22,642
+19,876
+719% +$4.83M 0.09% 194
2025
Q2 		$605K Sell
2,766
-23
-0.8% -$4.92K 0.03% 352
2025
Q1 		$624K Sell
2,789
-576
-17% -$159K 0.04% 258
2024
Q4 		$1.1M Sell
3,365
-120
-3% -$37.8K 0.07% 166
2024
Q3 		$1.05M Buy
3,485
+1,132
+48% +$347K 0.09% 116
2024
Q2 		$775K Buy
2,353
+238
+11% +$84.1K 0.08% 134
2024
Q1 		$837K Buy
2,115
+832
+65% +$308K 0.09% 116
2023
Q4 		$452K Buy
1,283
+64
+5% +$22.6K 0.05% 169
2023
Q3 		$458K Buy
1,219
+786
+182% +$304K 0.06% 150
2023
Q2 		$166K Hold
433
– – 0.02% 270
2023
Q1 		$150K Buy
433
+12
+3% +$3.51K 0.02% 280
2022
Q4 		$99.1K Buy
+421
New +$99.8K 0.01% 334
2022
Q3 		– Sell
-12
Closed -$4K – 1270
2022
Q2 		$4K Sell
12
-9
-43% -$2.93K ﹤0.01% 861
2022
Q1 		$9K Hold
21
– – ﹤0.01% 676
2021
Q4 		$10K Hold
21
– – ﹤0.01% 669
2021
Q3 		$9K Sell
21
-32
-60% -$13.5K ﹤0.01% 669
2021
Q2 		$19K Buy
+53
New +$17.5K ﹤0.01% 589

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Arax Advisory Partners's WST Position: Q2 2026 in Review

Arax Advisory Partners increased its West Pharmaceutical (WST) stake by 59% in Q2 2026, buying an estimated $443K and bringing the position to 3,908 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #1020.

Arax Advisory Partners first reported a position in WST in Q2 2021 and has held it in 20 quarters since. The position peaked at $5.94M in Q3 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Arax Advisory Partners held 3,908 shares of West Pharmaceutical worth $1.4M as of Q2 2026.
  • Arax Advisory Partners bought 1,450 West Pharmaceutical shares in Q2 2026, an estimated $443K.
  • West Pharmaceutical made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1020 holding.
  • Arax Advisory Partners first reported a position in West Pharmaceutical in Q2 2021 and has held it in 20 quarters since.
  • Arax Advisory Partners's West Pharmaceutical position peaked at $5.94M in Q3 2025.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.